Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Deferred Taxes: 2021-2025

Historic Deferred Taxes for Veracyte (VCYT) over the last 5 years, with Sep 2025 value amounting to -$87,000.

  • Veracyte's Deferred Taxes fell 569.23% to -$87,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$256,000, marking a year-over-year increase of 91.66%. This contributed to the annual value of -$233,000 for FY2024, which is 94.06% up from last year.
  • As of Q3 2025, Veracyte's Deferred Taxes stood at -$87,000, which was down 247.46% from $59,000 recorded in Q2 2025.
  • Veracyte's 5-year Deferred Taxes high stood at $143,000 for Q2 2024, and its period low was -$3.8 million during Q1 2021.
  • In the last 3 years, Veracyte's Deferred Taxes had a median value of -$50,000 in 2024 and averaged -$416,700.
  • Data for Veracyte's Deferred Taxes shows a peak YoY increase of 208.70% (in 2023) and a maximum YoY decrease of 1,860.51% (in 2023) over the last 5 years.
  • Veracyte's Deferred Taxes (Quarterly) stood at -$961,000 in 2021, then skyrocketed by 83.66% to -$157,000 in 2022, then plummeted by 1,860.51% to -$3.1 million in 2023, then spiked by 92.11% to -$243,000 in 2024, then tumbled by 569.23% to -$87,000 in 2025.
  • Its Deferred Taxes stands at -$87,000 for Q3 2025, versus $59,000 for Q2 2025 and $15,000 for Q1 2025.